NCT05704920 Integrating Artificial Intelligence Into Lung Cancer Screening. Status RECRUITING Phase NA
NCT05704634 A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05699213 MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening Status RECRUITING Phase N/A
NCT05697198 PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine Status COMPLETED Phase N/A
NCT05690945 A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05681962 Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy Status RECRUITING Phase N/A
NCT05677958 Protein Intake in Patients With Colorectal or Lung Cancer When Receiving a Nutritional Supplement Status COMPLETED Phase NA
NCT05674227 Cost-effectiveness Evaluation of Robotic Surgery in the Removal of Lung Lesions in the ATS of Milan Status UNKNOWN Phase N/A
NCT05672394 US-Guided Serratus Anterior Plane Block Versus Thoracic Epidural in Patients Undergoing Thoracotomy Status COMPLETED Phase NA
NCT05671887 DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies Status RECRUITING Phase N/A
NCT05669586 Organoids Predict Therapeutic Response in Patients With Multi-line Drug-resistant Lung Cancer Status RECRUITING Phase PHASE2
NCT05663242 The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action Status RECRUITING Phase PHASE4
NCT05655663 Evaluation of Vascular Toxicity of Immune Checkpoint Inhibitors in Patients Head and Neck or Lung Cancer Status RECRUITING Phase NA
NCT05654675 Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET Status RECRUITING Phase N/A
NCT05653531 Clinical Significance of Hepatic Biomarkers in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors Status WITHDRAWN Phase NA
NCT05652712 A Real-World Study of Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study) Status UNKNOWN Phase N/A
NCT05649046 Structuring of a Lung Cancer Screening Program Including Clinical, Radiological and Biological Phenotyping Useful for the Development of Individualized Risk Prediction Tools: PREVALUNG ETOILE Status ACTIVE_NOT_RECRUITING Phase NA
NCT05645731 Lung Cancer Screening in Family Members and Peers of Lung Cancer Patients: a Prospective Cohort Study Status COMPLETED Phase N/A